Provided by Tiger Trade Technology Pte. Ltd.

Zenas BioPharma Inc.

23.26
+1.466.70%
Volume:317.56K
Turnover:7.36M
Market Cap:1.47B
PE:-2.64
High:23.83
Open:21.96
Low:21.94
Close:21.80
52wk High:44.60
52wk Low:8.91
Shares:63.13M
Float Shares:39.84M
Volume Ratio:0.83
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8231
EPS(LYR):-8.4448
ROE:-137.11%
ROA:-29.06%
PB:4.37
PE(LYR):-2.75

Loading ...

Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence